Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             26 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A novel 5’ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma He, Zhengfu

158 C p. 164-165
artikel
2 A Novel Nonreciprocal/Reciprocal ALK Translocation Cause ALK+ in NSCLC Chen, Xianguo

158 C p. 162-163
artikel
3 Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial Lavole, Armelle

158 C p. 146-150
artikel
4 Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy He, Li-Na

158 C p. 1-8
artikel
5 Contents
158 C p. v-vi
artikel
6 Corrigendum to “A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients” [Lung Cancer 147 (2020) 259–268] Wang, Zhijie

158 C p. 166-167
artikel
7 Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT) Ingley, Katrina M.

158 C p. 151-155
artikel
8 Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration Cytryn, Samuel

158 C p. 15-17
artikel
9 Editorial Board
158 C p. iii
artikel
10 Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 – Systematic review and meta-analysis Tomasik, Bartłomiej

158 C p. 97-106
artikel
11 Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis Liu, Lihui

158 C p. 74-84
artikel
12 Endobronchial ultrasound for T4 staging in patients with resectable NSCLC Kuijvenhoven, Jolanda C.

158 C p. 18-24
artikel
13 Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC Zhang, Shannon S.

158 C p. 126-136
artikel
14 Incidence of tuberculosis in advanced lung cancer patients treated with immune checkpoint inhibitors – A nationwide population-based cohort study Kim, Hyung Woo

158 C p. 107-114
artikel
15 Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma Lu, Ao

158 C p. 29-39
artikel
16 Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations Göker, Erdem

158 C p. 60-73
artikel
17 NRG1 fusions: Biology to therapy Liu, Stephen V.

158 C p. 25-28
artikel
18 Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort Borg, Morten

158 C p. 85-90
artikel
19 Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients Nakasone, Shoko

158 C p. 115-125
artikel
20 Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution Di Stasio, G.D.

158 C p. 40-46
artikel
21 Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non–small cell lung cancer patients treated with osimertinib Liu, Renpeng

158 C p. 156-161
artikel
22 Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment Su, Po-Lan

158 C p. 137-145
artikel
23 The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study Sato, Tomo

158 C p. 9-14
artikel
24 The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in non-small cell lung cancer: A retrospective analysis based on the SEER database Qi, Mengfan

158 C p. 47-54
artikel
25 Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations Fekkar, Amal

158 C p. 55-59
artikel
26 Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas Yoshida, Chihiro

158 C p. 91-96
artikel
                             26 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland